Lymph node ratio predicts local recurrence for periampullary tumours

ANZ Journal of Surgery

Volumn 84, Issue 5, 2014, Pages 353-358

  Lee, Sung Ryol ^a   Kim, Hyung Ook ^a   Park, Yong Lai ^a   Shin, Jun Ho ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Curative pancreaticoduodenectomy; Metastatic lymph node ratio; Periampullary cancer; Prognostic factor

Indexed keywords

COMMON BILE DUCT NEOPLASMS; FEMALE; FORECASTING; HUMAN; LYMPH NODE; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PANCREATICODUODENECTOMY; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE; VATER PAPILLA;

AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; FORECASTING; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PANCREATICODUODENECTOMY; PROGNOSIS;

EID: 84899490850     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12129     Document Type: Article

References (23)

1. Benassai G, Mastrorilli M, Mosella F, Mosella G. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma. J. Exp. Clin. Cancer Res. 1999; 18: 23-28.
2. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann. Surg. 2003; 237: 74-85.
3. Sohn TA, Yeo CJ, Cameron JL etal. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J. Gastrointest. Surg. 2000; 4: 567-579.
4. Han SS, Jang JY, Kim SW etal. Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 2006; 32: 271-275.
5. Riediger H, Makowiec F, Fischer E, Adam U, Hopt UT. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J. Gastrointest. Surg. 2006; 10: 1106-1115.
6. House MG, Gonen M, Jarnagin WR etal. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J. Gastrointest. Surg. 2007; 11: 1549-1555.
7. Pawlik TM, Gleisner AL, Cameron JL etal. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141: 610-618.
8. Berger AC, Watson JC, Ross EA, Hoffman JP. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am. Surg. 2004; 70: 235-240.
9. Sierzega M, Popiela T, Kulig J, Npwak K. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 2006; 33: 240-245.
10. Brown KM, Tompkins AJ, Yong S, Aranha GV, Shoup M. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch. Surg. 2005; 140: 529-532.
11. Hsu HP, Yang TM, Hsieh YH, Shan YS, Lin PW. Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann. Surg. Oncol. 2007; 14: 50-60.
12. Bettschart V, Rahman MQ, Engelken FJ, Madhavan KK, Parks RW, Garden OJ. Presentation, treatment and outcome in patients with ampullary tumours. Br. J. Surg. 2004; 91: 1600-1607.
13. Sakata E, Shirai Y, Yokoyama N, Wakai T, Sakata J, Hatakeyama K. Clinical significance of lymph node micrometastasis in ampullary carcinoma. World J. Surg. 2006; 30: 985-991.
14. Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann. Surg. Oncol. 2010; 17: 991-997.
15. Winter JM, Cameron JL, Campbell KA etal. 1423 pancreaticoduodenectomies for pancreatic cancer: a single institution experience. J. Gastrointest. Surg. 2006; 10: 1199-1210.
16. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J. Surg. 2003; 27: 324-329.
17. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann. Surg. 2007; 245: 717-725.
18. Rosenberg R, Friederichs J, Schuster T etal. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3026 patients over a 25-year time period. Ann. Surg. 2008; 248: 968-978.
19. Lee SR, Kim HO, Son BH, Shin JH, Yoo CH. Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World J. Surg. 2012; 36: 1096-1101.
20. Bilici A, Seker M, Ustaalioglu BB etal. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer. Med. Oncol. 2010; 27: 975-984.
21. Saito H, Fukumoto Y, Osaki T etal. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J. Surg. Oncol. 2008; 97: 132-135.
22. Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003; 229: 3-8.
23. Zhou XH, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. New York: Wiley, 2002; 15-164.